Results 241 to 250 of about 581,379 (326)
Current Understanding of Protein Aggregation in Neurodegenerative Diseases. [PDF]
Hu C, Lin M, Wang C, Zhang S.
europepmc +1 more source
Mitochondrial genome changes and neurodegenerative diseases
Milena Pinto, Carlos T. Moraes
openalex +1 more source
This study develops gallium‐doped V2C MXene nanozymes (Ga‐V2C) to treat acetaminophen‐induced liver injury through multi‐death pathway blockade and hepatocyte regeneration. Unlike conventional single‐target therapies like N‐acetylcysteine, Ga‐V2C nanozymes enable oxidative stress suppression, apoptosis, and ferroptosis inhibition, and enhanced ...
Xiaopeng Cai +13 more
wiley +1 more source
Tubular ER dysfunction in neurodegenerative diseases. [PDF]
Sharoar MG, Yan R.
europepmc +1 more source
Stochastic nanoscale physical cues induce glioblastoma (GBM)‐associated transcriptional traits in naïve astrocytes leading to spontaneous formation of spheroids. Cells within spheroids express activated‐MMP2 and a differential gene expression pattern involving P53 and NOTCH3, providing evidence for a role for changes in brain topography, as observed in
Laurent Starck +8 more
wiley +1 more source
Synaptic Plasticity in Neurodegenerative Diseases: Impact of Exercise as Promising Therapeutic Tool. [PDF]
Farina G +3 more
europepmc +1 more source
Protein network analysis reveals selectively vulnerable regions and biological processes in FTD [PDF]
Karch, Celeste M. +2 more
core +1 more source
Phosphorylation of Optineurin by TBK1 induces the formation of filaments that condensate upon binding to linear polyubiquitin. Membrane‐anchored LC3 partitions into these condensates, suggesting that phase separation of filamentous Optineurin with ubiquitylated cargo promotes the sequestration of cargo and its subsequent alignment with LC3‐positive ...
Maria G. Herrera +10 more
wiley +1 more source

